2901-78-2 Usage
Description
N-BENZOYL-4-HYDROXY-3-METHOXY-PHENYLALANINE, also known as N-Benzoyl-3-methoxytyrosine, is an organic compound that serves as an intermediate in the synthesis of various pharmaceutical compounds. It is characterized by its unique chemical structure, which includes a benzoyl group, a hydroxyl group, and a methoxy group attached to a phenylalanine backbone. N-BENZOYL-4-HYDROXY-3-METHOXY-PHENYLALANINE plays a crucial role in the development of medications for various medical applications.
Uses
Used in Pharmaceutical Synthesis:
N-BENZOYL-4-HYDROXY-3-METHOXY-PHENYLALANINE is used as an intermediate in the synthesis of rac 3-O-Methyl DOPA (M303805), which is an impurity of Levodopa (D533751). This application is essential for the development of medications used in the treatment of Parkinson's disease and other related conditions.
Used in Diagnostic Applications:
N-BENZOYL-4-HYDROXY-3-METHOXY-PHENYLALANINE is used as a marker for screening the absence of Aromatic L-amino acid decarboxylase (AADC). This enzyme is involved in the conversion of Levodopa to dopamine, and its deficiency can lead to various neurological disorders. The use of N-Benzoyl-3-methoxytyrosine as a marker aids in the early detection and diagnosis of these conditions, enabling timely intervention and treatment.
Check Digit Verification of cas no
The CAS Registry Mumber 2901-78-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,9,0 and 1 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 2901-78:
(6*2)+(5*9)+(4*0)+(3*1)+(2*7)+(1*8)=82
82 % 10 = 2
So 2901-78-2 is a valid CAS Registry Number.
InChI:InChI=1/C17H17NO5/c1-23-15-10-11(7-8-14(15)19)9-13(17(21)22)18-16(20)12-5-3-2-4-6-12/h2-8,10,13,19H,9H2,1H3,(H,18,20)(H,21,22)
2901-78-2Relevant articles and documents
-
Fromherz,Hermanns
, p. 221 (1914)
-
A modified synthesis of (±)-β-aryllactic acids
Wong,Xu,Chang,Lee
, p. 793 - 797 (2007/10/02)
The synthesis of racemic forms of the reportedly active principle of Danshen, namely (±)-β-(3,4-dihydroxyphenyl)lactic acid [(±)3-(3,4-dihydroxyphenyl)-2-hydroxypropanoic acid] and its seven racemic derivatives is reported.
